Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study).
Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F; Under the auspices of the Association of Interventional Cardiology of the Spanish Society of Cardiology. Alfonso F, et al. Among authors: rivero f. Am J Cardiol. 2022 Jan 1;162:31-40. doi: 10.1016/j.amjcard.2021.09.027. Am J Cardiol. 2022. PMID: 34903344 Clinical Trial.
Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2).
de la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, Pérez de Prado A, Rivero F, Sanchis J, Larman M, Diaz JF, Elizaga J, Moreiras JM, Gomez Jaume A, Hernández JM, Mauri J, Recalde AS, Bullones JA, Rumoroso JR, Del Blanco BG, Baz JA, Bosa F, Botas J, Hernández F; ESTROFA-2 Study Group. de la Torre Hernández JM, et al. Among authors: rivero f. JACC Cardiovasc Interv. 2010 Sep;3(9):911-9. doi: 10.1016/j.jcin.2010.06.010. JACC Cardiovasc Interv. 2010. PMID: 20850089 Free article.
Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study.
de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, Rumoroso JR, Lopez-Palop R, Sadaba M, Carrillo P, Rondan J, Lozano I, Ruiz Nodar JM, Baz JA, Fernandez Nofrerias E, Pajin F, Garcia Camarero T, Gutierrez H; LITRO Study Group (Spanish Working Group on Interventional Cardiology). de la Torre Hernandez JM, et al. J Am Coll Cardiol. 2011 Jul 19;58(4):351-8. doi: 10.1016/j.jacc.2011.02.064. J Am Coll Cardiol. 2011. PMID: 21757111 Free article. Clinical Trial.
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).
De la Torre Hernandez JM, Alfonso F, Sanchez Recalde A, Jimenez Navarro MF, Perez de Prado A, Hernandez F, Abdul-Jawad Altisent O, Roura G, Garcia Camarero T, Elizaga J, Rivero F, Gimeno F, Calviño R, Moreu J, Bosa F, Rumoroso JR, Bullones JA, Gallardo A, Fernandez Diaz JA, Ruiz Arroyo JR, Aragon V, Masotti M; ESTROFA-LM Study Group. De la Torre Hernandez JM, et al. Among authors: rivero f. Am J Cardiol. 2013 Mar 1;111(5):676-83. doi: 10.1016/j.amjcard.2012.11.019. Epub 2012 Dec 27. Am J Cardiol. 2013. PMID: 23273715 Clinical Trial.
Current treatment of in-stent restenosis.
Alfonso F, Byrne RA, Rivero F, Kastrati A. Alfonso F, et al. Among authors: rivero f. J Am Coll Cardiol. 2014 Jun 24;63(24):2659-73. doi: 10.1016/j.jacc.2014.02.545. Epub 2014 Mar 13. J Am Coll Cardiol. 2014. PMID: 24632282 Free article. Review.
Spontaneous coronary artery dissection.
Alfonso F, Bastante T, Rivero F, Cuesta J, Benedicto A, Saw J, Gulati R. Alfonso F, et al. Among authors: rivero f. Circ J. 2014;78(9):2099-110. doi: 10.1253/circj.cj-14-0773. Epub 2014 Aug 13. Circ J. 2014. PMID: 25131524 Free article.
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis).
Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García Del Blanco B, García-Touchard A, López-Minguéz JR, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernández-Ortíz A, Escaned J, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C; Restenosis Intra-stent: drug-eluting Balloon vs. everolimus-eluting Stent (RIBS IV) Study Investigators (under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology). Alfonso F, et al. Among authors: rivero f. EuroIntervention. 2015 Jul;11(3):336-42. doi: 10.4244/EIJY14M09_07. EuroIntervention. 2015. PMID: 25244700 Free article. Clinical Trial.
343 results